company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52382000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1964000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,155000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1196000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55697000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,320000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,158000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2301000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,,totalassets,Total Assets,=,debit,usd,57998000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1143000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,294000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1437000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,94000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,94000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1531000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,359089000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-302796000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,174000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,56467000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,56467000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,56467000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,,2011-06-30,2011-08-12 16:31:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,57998000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52388000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2047000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,82000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1296000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55813000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,320000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,152000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2137000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,,totalassets,Total Assets,=,debit,usd,57950000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,880000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,400000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1280000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1280000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,359239000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-302743000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,174000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,56670000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,56670000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,56670000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,,2011-09-30,2011-11-14 16:30:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,57950000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,138918000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10831000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1816000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,151565000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1325000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,8109000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,65000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16709000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,,totalassets,Total Assets,=,debit,usd,169599000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1497000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4748000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10621000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16866000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,554000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,554000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17420000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,275376000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-123193000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,152179000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,152179000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,152179000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,,2012-03-31,2012-05-09 07:55:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,169599000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,138859000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1602000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1970000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,142431000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1720000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7435000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,43000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16013000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,,totalassets,Total Assets,=,debit,usd,160164000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,491000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6092000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10483000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17066000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,60000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,60000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,276462000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-133416000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,143038000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,143038000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,143038000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,,2012-06-30,2012-08-03 08:02:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,160164000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,233407000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2622000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1700000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,237729000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3997000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6441000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,68000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15044000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,,totalassets,Total Assets,=,debit,usd,256770000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1234000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4827000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7687000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13748000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13748000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,386627000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-143598000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,243022000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,243022000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,243022000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,,2012-09-30,2012-11-06 09:16:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,256770000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53762000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,255180000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2593000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8229000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,319764000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7276000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4865000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,713000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14113000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,,totalassets,Total Assets,=,debit,usd,341153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3548000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4629000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2472000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10649000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10649000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,503765000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-173273000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,12000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,330504000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,330504000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,330504000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,,2013-03-31,2013-05-07 16:28:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,341153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47760000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,237068000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3806000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8941000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,297575000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13207000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4159000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,715000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13409000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,,totalassets,Total Assets,=,debit,usd,324191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2443000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8052000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12648000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,717000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,717000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13365000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,506221000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-195380000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-15000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,310826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,310826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,310826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,,2013-06-30,2013-08-07 16:49:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,324191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,216870000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,218607000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1142000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6609000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,443228000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15527000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3867000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,726000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13128000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,,totalassets,Total Assets,=,debit,usd,471883000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1545000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10142000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1835000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13522000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1573000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1573000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15095000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,680275000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-223503000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,456788000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,456788000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,456788000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,,2013-09-30,2013-11-04 06:52:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,471883000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,152331000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,422887000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1446000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8925000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,585589000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,23647000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3102000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2231000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13868000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,,totalassets,Total Assets,=,debit,usd,623104000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2512000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13929000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,93000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,653000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17187000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4825000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4825000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22012000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,891768000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-290663000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-13000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,601092000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,601092000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,601092000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,,2014-03-31,2014-05-01 16:33:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,623104000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,70453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,464048000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2241000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8899000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,545641000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30369000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2565000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6125000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,17225000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,,totalassets,Total Assets,=,debit,usd,593235000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4620000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,22008000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,641000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27269000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5352000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5352000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,32621000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,901568000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-340903000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-51000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,560614000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,560614000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,560614000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,,2014-06-30,2014-07-31 06:12:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,593235000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,76537000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,411845000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1362000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10382000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,500126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,31324000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2247000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5974000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16756000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,,totalassets,Total Assets,=,debit,usd,548206000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3008000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19434000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,660000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23102000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5464000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5464000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28566000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,908935000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-389222000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-73000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,519640000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,519640000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,519640000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,,2014-09-30,2014-10-30 16:18:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,548206000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98577000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,611984000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,926000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10791000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,722278000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,31917000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8535000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1781000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4035000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14351000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,,totalassets,Total Assets,=,debit,usd,768546000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2080000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,24801000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,971000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27852000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5568000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5568000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33420000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1241890000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-506488000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-276000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,735126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,735126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,735126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,,2015-03-31,2015-04-30 16:15:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,768546000.0
